Status
Conditions
Treatments
About
COVID-19 is associated with acute pulmonary and cardiac injury. To better understand the degree and severity of cardiopulmonary injury as well as short and long-term sequelae of COVID-19 infection, this study will perform longitudinal study in patients who had recent known diagnosis of COVID-19.
Full description
The objectives for this study include providing structural and function information about lung and heart using chest imaging, MRI, Echo, Spirometry, and blood markers in order to assess severity of cardiopulmonary injury and short- and long-term sequelae of COVID-19 infection as well as assess indicators of mental health and quality of life.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
CONTROL Inclusion Criteria
Exclusion criteria
• Participants cannot sign consent
Any individual who meets any of the following criteria will be excluded from participation to the MRI or x-ray portion of the study:
CONTROL Exclusion Criteria
Patients with any of the following are excluded from as controls:
1,500 participants in 2 patient groups
Loading...
Central trial contact
Ashley Witzl; Daniel Walsh
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal